Nutrition screening within the community for older adults continues to be a challenge despite tremendous advances through the years. This webinar will address nutrition screening (past, present and future) and will specifically address undernutrition in the aging adult. Available community intervention resources, which target undernutrition in the older adult population, will also be discussed.
Supported by Nestlé Health Science
This webinar was chosen as a platform for providing updates regarding
the ASPEN 2022 Nutrition Assessment Survey, validation of the AND/ASPEN
characteristics for diagnosing malnutrition, as well as discussing the
practicalities of integration of the AND/ASPEN and GLIM criteria for
diagnosing malnutrition into clinical practice.
Supported by BAXTER
As both malnutrition research and information related to malnutrition interventions evolve, it has been proposed that standardization of diagnosing, intervening, and monitoring is feasible and beneficial for patient outcomes. This webinar will discuss the Global Malnutrition Composite Score and what it means for current practice as well as the Canadian Malnutrition Standard in addressing malnutrition utilizing quality measures.
This webinar will serve as a platform for selected researchers to expound on their notable, cutting-edge publications from 2021-2022 relating to the characteristics and factors of malnutrition with regard to diagnosing and outcomes of malnutrition within the adult and pediatric populations. It will also serve as a method for audience members to correspond with the authors on how these publications may be applicable to their practice.
Treatment interventions for malnutrition differ depending on a patient’s disease state and age. In this webinar, two challenging disease states, hepatic and renal diseases, and the differences in treatment for malnutrition will be discussed. A focus on both adult and pediatric patients will be incorporated to highlight the differences in malnutrition management across the age spectrum in the setting of these two disease states.